Results 211 to 220 of about 52,218 (248)

D-PENICILLAMINE AND POLYMYOSITIS: THE SIGNIFICANCE OF THE ANTI-JO-1 ANTIBODY

Rheumatology, 1993
A 57-yr-old lady developed polymyositis whilst taking D-penicillamine for RA. D-Penicillamine-induced polymyositis occurs in RA with a greater frequency than idiopathic polymyositis. Anti-acetyl choline receptor antibodies and ANA were positive, consistent with drug-induced disease.
E A, Jenkins, R G, Hull, A L, Thomas
openaire   +2 more sources

Primary lung adenocarcinoma associated with anti-Jo-1 positive polymyositis

Joint Bone Spine, 2011
We present a female with anti-Jo-1 positive polymyositis and lung adenocarcinoma. Her polymyositis diagnosis was based on her clinical symptoms, electromyography results, and highly elevated muscle enzymes, including creatine kinase and lactate-dehydrogenase.
Melinda, Vincze, Peter A, Molnár, Erika, Zilahi, Anikó, Kapitány, Balázs, Dezso, István, Takács, Katalin, Dankó   +6 more
openaire   +2 more sources

Anti-Jo-1 antibodies

Revue Tunisienne de BIOLOGIE CLINIQUE, Vol. 31 No 2 (2024): Edition spéciale : «Auto-anticorps : le mystère révélé»
Letifi, Wafa, Jaziri, Imen
openaire   +1 more source

Interstitial lung disease as the presentation of anti-Jo-1 positive polymyositis

Clinical Rheumatology, 1987
A patient presenting with interstitial lung disease was predicted to have underlying polymyositis when found to be anti-Jo-1 antibody positive. When myopathy developed later with elevated serum creatine phosphokinase and myoglobin levels, the electromyogram was nonmyopathic, and polymyositis was confirmed by muscle biopsy.
P, Nash, L, Schrieber, J, Webb
openaire   +2 more sources

The long-term outcome of anti-Jo-1-positive inflammatory myopathies

Journal of Neurology, 2004
To determine the response to treatment and the long-term outcome of patients with the antisynthetase syndrome associated with anti-Jo-1-antibodies.A total of 12 patients with histologically proven myositis and anti-Jo-1-autoantibodies were evaluated over a mean follow-up period of 66.4 months.
Michael, Späth, Mira, Schröder, Beate, Schlotter-Weigel, Maggie C, Walter, Hubert, Hautmann, Gerda, Leinsinger, Dieter, Pongratz, Wolfgang, Müller-Felber   +7 more
openaire   +2 more sources

Fatal interstitial pulmonary fibrosis in anti-Jo-1–negative amyopathic dermatomyositis

Journal of the American Academy of Dermatology, 2003
Amyopathic dermatomyositis (DM) describes a subpopulation with the cutaneous eruption of DM, but without muscle involvement. Interstitial pulmonary fibrosis is a recognized complication of DM, often correlated with antisynthetase enzymes, such as anti-Jo-1. We describe a case of fatal IPF in a patient with anti-Jo-1 antibody-negative amyopathic DM.
Whitney A, High, Jack B, Cohen, Bettina A, Murphy, Melissa I, Costner   +3 more
openaire   +2 more sources

Anti-Jo-1 antibody in patients with polymyositis/dermatomyositis.

Zhonghua Minguo wei sheng wu ji mian yi xue za zhi = Chinese journal of microbiology and immunology, 1993
Interstitial lung disease (ILD) has been recognized as a manifestation of polymyositis or dermatomyositis (PM/DM). Patients with PM/DM with anti-Jo-1 antibody had a higher incidence of ILD. Thirty-five patients with PM/DM were studied the antibodies. Six (16.1%) were found to have them.
C C, Leu, J L, Lan
openaire   +1 more source

Adult respiratory distress syndrome in polymyositis patients with the anti–jo‐1 antibody

Arthritis & Rheumatism, 1995
AbstractWe report 3 patients with polymyositis and the anti–Jo‐1 antibody who developed fatal adult respiratory distress syndrome (ARDS). Other than the presence of the anti–Jo‐1 antibody, there were no other consistent clinical features at the onset of disease that were predictive of ARDS development.
K, Clawson, C V, Oddis
openaire   +2 more sources

Dermatomyositis: an association of gingival telangiectases and anti Jo-1 antibody in the adult.

Acta dermatovenerologica Alpina, Pannonica, et Adriatica, 2007
The presence of gingival telangiectases is an unusual clinical finding in adults with dermatomyositis (DM). Patients with aminoacyl-tRNA synthetase autoantibodies express one or more of the following features: myositis, interstitial lung disease, "mechanicns hands", and capillary abnormalities (facial telangiectases and Raynaudns phenomenon).A 45-year ...
Dourmishev, Assen L., Dourmishev, Lyubomir, Schwartz, Robert A.   +2 more
openaire   +2 more sources

[Preliminary report on the clinical application of anti-Jo-1 antibody].

Zhonghua nei ke za zhi, 1990
Jo-1 antigen was purified from the rabbit thymus acetone powder. Using it as antigen, we found anti-Jo-1 antibody in 25% of polymyositis, 7.1% in dermatomyositis, none in other connective tissue diseases nor non-connective tissue diseases. Other antinuclear antibodies, eg anti-RNP, anti-SSA were also found in our polymyositis-dermatomyositis patients ...
Y, Dong, P C, Cheng, N C, Zhang
openaire   +1 more source